 PARSIPPANY, NJ, Feb. 04, 2021 GLOBE NEWSWIRE -- Interpace Biosciences, Inc. NASDAQ: IDXG Interpace a leader in enabling personalized medicine, announced today that its Board of Directors has appointed Tom Freeburg, Chief Accounting Officer, as Interpaces Chief Financial Officer CFO. Mr. Freeburg succeeds Fred Knechtel effective February 1, 2021. 